In this study, metformin increased whole body insulin-stimulated glucose uptake, but the effect was exclusively observed in patients with T2D and obesity, highlighting the paradoxical effects of metformin in lean vs. obese individuals [25,26]. The gene discussed is INS; the disease is Obesity.